Monopar Therapeutics

MNPRNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$648.597 M

$96.63 +0.95%

Close of 22 Sept 2026

Revenue

$0.00

#3637 by revenue

Earnings

-$13.7M

Loss-making

Shares outstanding

6,712,172

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#189AltimmuneALT$663.3M
#190Shattuck LabsSTTK$652.4M
#191Monopar TherapeuticsMNPR$648.6M
#192CytomX TherapeuticsCTMX$640.6M
#193Phathom PharmaceuticalsPHAT$627.8M

What if Monopar Therapeutics were worth as much as…

Open the what-if tool →

Gold $30.2T

$4,504,350

Per share 46,614× higher

Bitcoin $1.74T

$259,477.12

Per share 2,685× higher

Nvidia $5.52T

$821,755.91

Per share 8,504× higher

Or at a round number

$1.00B $2.00B $5.00B $10.0B

Where these numbers come from

Share counts and financials for Monopar Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.